Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Dandona Paresh and Mathieu Chantal and Phillip Moshe and Hansen Lars and Griffen Steven C and Tschöpe Diethelm and Thorén Fredrik and Xu John and Langkilde Anna Maria and Kollaboráció szervezet: DEPICT-1 Investigators and Piros Györgyike Ágnes and et al. (kollab. közrem.): Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
LANCET DIABETES & ENDOCRINOLOGY, 5 (11). pp. 864-876. ISSN 2213-8587 (2017)

[thumbnail of Dandona.pdf] Text
Dandona.pdf - Published Version

Download (391kB)
Item Type: Journal Article
Szerzők száma: 161
Journal or Publication Title: LANCET DIABETES & ENDOCRINOLOGY
Date: 2017
Volume: 5
Number: 11
Page Range: pp. 864-876
ISSN: 2213-8587
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 27156040
DOI azonosító: https://doi.org/10.1016/S2213-8587(17)30308-X
Date Deposited: 2023. Mar. 28. 13:10
Last Modified: 2023. Mar. 28. 13:10
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/26852
Web of Science® Times Cited: 216 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year